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The enigma of Hodgkin's disease etiology has fascinated several generations of
researchers. Of particular scientific interest has been the hypothesis that Hodgkin's
disease might have an infectious etiology. Thepaper by Mueller in this issuechronicles
thedevelopment ofthe important workoftwo generations ofinvestigators (herselfand
Dr. Alfred S. Evans) trying to explicate the role of viruses, particularly the Epstein-
Barr virus (EBV), in the causation ofthis disease.
Almost from its first description in 1832 by Thomas Hodgkin, Hodgkin's disease has
been suspected ofhaving an infectious agent as its cause [1]. This idea is not surprising
since one of Hodgkin's original seven cases was found to be a case of syphilis and a
second case to be questionable tuberculosis when Fox reviewed pathological materials
from the cases in 1926 [2]. At the end of the last century, Hodgkin's disease was
frequently found in association with tuberculosis, leading Sternberg to conclude that
Hodgkin's disease might be an unusual form of tuberculosis [3]. At the turn of the
century, the discovery of the Sternberg-Reed cell, which appeared to be pathognomic
for Hodgkin's disease, helped greatly in weeding out several diseases which had
previously been confused with Hodgkin'sdisease [3]. The beliefthat Hodgkin's disease
had an infectious cause, however, persisted well into the 1940s. This fact is evidenced
by the inclusion of Hodgkin's disease under the category of infectious and parasitic
diseases in the Fourth Revision ofthe International Classification of Causes of Death
[4].
The issue of possible transmissibility of Hodgkin's disease was revived in the 1970s
bythe workofVianna and hiscolleagues inAlbany, New York [5,6]. They reported an
unusual occurrence ofHodgkin's disease involving members ofa particular high school
class and their direct and indirect contacts. Their report of an aggregate of 31 cases
that could be interlinked by personal contact constituted the largest cancer "cluster"
reported in the literature. The meaning of this finding was inevaluable statistically,
however. As a result, the Albany group did a systematic study of the occurrence of
Hodgkin's disease in high schools in the Long Island area of New York State. They
found that a child attending a high school where a case ofHodgkin's disease had been
in attendance had a twofold to fifteenfold increased risk ofdeveloping the disease [7].
A replication of the Long Island study in the greater Boston area failed to confirm
Vianna and Polan's findings [8]. Additional studies from the UK and the State of
Washington also failed to support the Long Island study's striking findings [9,10].
329
Supported by grants (ROI CA44706 and ROI CA39163) from the National Cancer Institute, Bethesda,
MD
*Present address: Pittsburgh Cancer Institute, 230 Lothrop Street, Pittsburgh, PA 15213-2592
Copyright ©1987 by The Yale Journal of Biology and Medicine, Inc.
All rights ofreproduction in any form reserved.SEYMOUR GRUFFERMAN
Thus it appears that Hodgkin's disease is not transmissible in schools. Nevertheless,
the work of Vianna and his colleagues did stir great interest again in the notion that
Hodgkin's disease might be an infectious disease.
The Epstein-Barr virus had been a favorite candidate virus for causing human
lymphomas since it was first isolated from tumor cells of an African patient with
Burkitt's lymphoma. The virus has been found to be the cause of infectious mononu-
cleosis in humans, but its etiologic role in Burkitt's lymphoma remains unclear [11]. It
seemed that the next logical thing to do was to evaluate the role of EBV in Hodgkin's
disease. Dr. Evans first suggested a possible role for the EBV in Hodgkin's disease in
1971 [12]. As Mueller points out, it was found that patients with Hodgkin's disease do
not have a higher prevalence of anti-EBV antibodies but that they had higher mean
titers of antibody than did matched controls. This finding, however, presented a
"chicken-and-egg" dilemma. Were the findings of higher antibody titers against the
EBV due to the underlying defect in cell-mediated immunity found in Hodgkin's
disease or did they antecede the disease? The answer to this question could only be
resolved by follow-upstudies. Millerand Beebe, in 1973, were thefirst tostudy the risk
ofHodgkin's disease in persons with prior diagnoses ofinfectious mononucleosis. They
found a relative risk of two for the association, but their study was so small that little
could beconcluded from it [4]. Connelly and Christine in 1974 did a follow-up studyof
a cohort ofover 4,000 persons with infectious mononucleosis and found a relative risk
of 3.7 for Hodgkin's disease [4]. It was, however, the study in 1974 by Rosdahl that
persuaded more people that the association might be valid [4]. Since then, there have
been several additional follow-up studies of risk of Hodgkin's disease in persons with
previously diagnosed infectious mononucleosis. The relative risks obtained, from these
studies have centered around three [4]. The major unresolved issue posed by these
follow-up studies was that of the temporal relationship between the diagnosis of
infectious mononucleosis and the onset of Hodgkin's disease. These studies did not
permit proper separation ofthe antecedent and subsequent diseases.
The most persuasive early evidence of a possible cause-effect relationship between
EBV infection and risk of Hodgkin's disease came from a study by Evans and
Comstock [13]. They used a serum bank containing sera from over 25,000 subjects in
Washington County, Maryland, to do their study. Two members of the cohort
developed Hodgkin's disease 11 and 21 months following the drawing of blood for
storage in the serum bank. The two cases had clearly altered patterns of antibodies
against EBV as compared to matched controls. These pilot data areconsistent with the
hypothesis that historyofinfectious mononucleosis confers an independently increased
risk of Hodgkin's disease.
To investigate further the intriguing association between the EBV and risk of
Hodgkin's disease, Mueller and Evans developed a large multi-center collaborative
study. Blood specimens from over 240,000 individuals for whom subsequent diagnoses
of malignancy could be determined formed the basis of their study. The investigators
performed a case-control study within this large cohort study. They found serum
specimens prior to Hodgkin's disease diagnosis for 43 persons; these were matched to
specimens drawn at the same time from 96 controls of the same age and sex. The
specimens were obtained from eight months to thirteen years prior to the cases'
diagnosis. The investigators found that antibody against the EBV viral capsid antigen
and the diffuse component of early antigen were significantly elevated among cases,
with relative risks of three and four, respectively. Furthermore, cases were distin-
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guished by elevated antibodies against EBV nuclear antigen and by the presence of
IgA antibodies against the viral capsid antigen. Patterns they observed in the
pre-diagnosis specimens were similar to those seen in the post-diagnosis specimens and
suggested chronic EBV replication.
What does all this mean? Theevidence overwhelmingly suggests that persons with a
history of serologically confirmed infectious mononucleosis have at least a threefold
increased risk of developing Hodgkin's disease. The latest findings of Mueller and
Evans, not all ofwhich areavailable at this time, suggestthat theantibody responses to
EBV clearly occurred in advance ofthe onset of Hodgkin's disease. Thus, the findings
cannot simply be attributed to the immunedysfunction seen in Hodgkin's disease. It is
unlikely that subjects would have had subclinical Hodgkin's disease for as long as
thirteen years prior to diagnosis. The question which arises next is whether the
Epstein-Barr virus might be an initiator or a promoter ofHodgkin's disease. It may be
that there is some underlying immune defect which predisposes individuals to both
EBV infection and Hodgkin's disease. The evidence suggests that the Epstein-Barr
virus is not a necessary cause of Hodgkin's disease. Not all cases ofHodgkin's disease
have serologic or clinical evidence of prior EBV infection. Furthermore, the EBV
genome has not been found in Hodgkin's disease tumor cells.
Mueller suggests that chronic EBV replication produces chronic antigenic stimula-
tion which in turn may lead to altered gene expression, resulting in the immune
dysfunction and cellular abnormality of Hodgkin's disease. I tend to doubt this
hypothesis sincechronic antigenic stimulation has been shown to have nosuch affect in
other lymphoreticular malignancies and, in fact, may have a protective effect. In
recent case-control studies of chronic lymphocytic leukemia, non-Hodgkin's lympho-
ma, and multiple myeloma, almost all conditions which produce chronic antigenic
stimulation appear to have odds ratios below one [14-16]. Many of these odds ratios
are statistically significantly below one. A protective effect of chronic antigenic
stimulation due to chronic or frequent infections is consonant with the "paralytic polio
model" of Hodgkin's disease. The last suggestion made by Mueller is that perhaps
chronic EBV expression is secondary to another more fundamental factor such as
another viral infection. Unfortunately, there are no current data for evaluating this
hypothesis further.
In summary, I believe that the association between EBV infection and subsequent
risk ofHodgkin's disease is clearly valid. As a result, one may consider prior history of
chronic infectious mononucleosis and serologic evidence of prior EBV infection as
markers of risk in Hodgkin's disease. The EBV is not a necessary cause of Hodgkin's
disease, based on the data at hand. This finding, however, should not denigrate the
importance of the observed association between evidence of EBV infection and
subsequent risk ofHodgkin's disease. It is likely that the EBV is part ofa complicated
"causal web" for Hodgkin's disease, and the association seems very promising for
further research. The next two questions which must be answered are: Is there some
underlying genetic or immunologic predisposition to both Hodgkin's disease and EBV
infection? Is there another virus which is the cause ofHodgkin's disease and leads to a
reactivation response to the EBV?
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